Lifecare AS

Oslo Stock Exchange LIFE.OL

Lifecare AS Return on Equity (ROE) for the year ending December 31, 2023: -53.10%

Lifecare AS Return on Equity (ROE) is -53.10% for the year ending December 31, 2023, a -67.86% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

Lifecare AS Return on Equity (ROE) for the year ending December 31, 2022 was -31.63%.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

Oslo Stock Exchange: LIFE.OL

Lifecare AS

CEO	Mr. Joacim Holter
IPO Date	July 11, 2018
Location	Norway
Headquarters	Ytrebygdsvegen 215
Employees	32
Sector	Health Care
Industries Medical Instruments Biotechnology Pharmaceuticals

Description

Lifecare AS engages in the research and development of medical sensors for health monitoring in Norway. It develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes. The company was founded in 2006 and is headquartered in Bergen, Norway.

Key trends

Past 5 years